| Literature DB >> 34573362 |
Ann Ying-An Chen1,2, Chao-Wei Huang3, Shyh-Hwa Liu4, An-Chi Liu1, Hso-Chi Chaung1,2.
Abstract
Enhancing resistance and tolerance to pathogens remains an important selection objective in the production of livestock animals. Single nucleotide polymorphisms (SNPs) vary gene expression at the transcriptional level, influencing an individual's immune regulation and susceptibility to diseases. In this study, we investigated the distribution of SNP sites in immune-related genes and their correlations with cell surface markers of immune cells within purebred (Taiwan black, Duroc, Landrace and Yorkshire) and crossbred (Landrace-Yorkshire) pigs. Thirty-nine SNPs of immune-related genes, including 11 cytokines, 5 chemokines and 23 Toll-like receptors (TLRs) (interferon-α and γ (IFN-α, γ), tumor necrosis factor-α (TNF-α), granulocyte-macrophage colony-stimulating factor (GM-CSF), Monocyte chemoattractant protein-1 (MCP-1) and TLR3, TLR4, TLR7, TLR8, and TLR9) were selected, and the percentages of positive cells with five cell surface markers of CD4, CD8, CD80/86, MHCI, and MHCII were analyzed. There were 28 SNPs that were significantly different among breeds, particularly between Landrace and Taiwan black. For instance, the frequency of SNP1 IFN-α -235A/G in Taiwan black and Landrace was 11.11% and 96.15%, respectively. In addition, 18 SNPs significantly correlated with the expression of cell surface markers, including CD4, CD8, CD80/86, and MHCII. The percentage of CD4+ (39.27%) in SNP33 TLR-8 543C/C was significantly higher than those in A/C (24.34%), at p < 0.05. Together, our findings show that Taiwan black pigs had a unique genotype distribution, whereas Landrace and Yorkshire had a more similar genotype distribution. Thus, an understanding of the genetic uniqueness of each breed could help to identify functionally important SNPs in immunoregulation.Entities:
Keywords: immune cells; immune-related genes; pig; single-nucleotide polymorphism
Mesh:
Substances:
Year: 2021 PMID: 34573362 PMCID: PMC8471458 DOI: 10.3390/genes12091377
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
The PCR analytic conditions and their production.
| SNP No. | SNPs | PCR | PCR Product (bp) | Restriction |
|---|---|---|---|---|
| SNP1 | IFN-α (-235) | 54 | 212 | * |
| SNP2 | IFN-γ (382) | 53 | 507 | * |
| SNP3 | IFN-γ (490) | 50 | 836 | SspI |
| SNP4 | TNF-α (366) | 54 | 352 | BtsCI |
| SNP5 | TNF-α (755) | 53 | 174 | * |
| SNP6 | TNF-α (1219) | 59 | 550 | * |
| SNP7 | GM-CSF (193) | 53 | 1046 | ApaLI |
| SNP8 | GM-CSF (245) | 55 | 437 | BccI |
| SNP9 | GM-CSF (741) | 53 | 421 | * |
| SNP10 | GM-CSF (753) | 53 | 1046 | BsoBI |
| SNP11 | GM-CSF (782) | 54 | 469 | TseI |
| SNP12 | MCP-1 (273) | 54 | 252 | * |
| SNP13 | MCP-1 (336) | 52 | 443 | BtsI |
| SNP14 | MCP-1 (351) | 52 | 443 | Bsp1286I |
| SNP15 | MCP-1 (360) | 52 | 443 | MseI |
| SNP16 | MCP-1 (383) | 52 | 443 | BtsCI |
| SNP17 | TLR 3 (95) | 53 | 926 | * |
| SNP18 | TLR 3 (159) | 55 | 857 | * |
| SNP19 | TLR 3 (405) | 55 | 616 | * |
| SNP20 | TLR 3 (800) | 53 | 221 | * |
| SNP21 | TLR 4 (-13) | 54 | 406 | * |
| SNP22 | TLR 7 (-332) | 47 | 331 | * |
| SNP23 | TLR 7 (66) | 55 | 562 | * |
| SNP24 | TLR 7 (357) | 55 | 272 | * |
| SNP25 | TLR 7 (1413) | 59 | 899 | * |
| SNP26 | TLR 7 (1633) | 55 | 677 | * |
| SNP27 | TLR 7 (2034) | 55 | 346 | * |
| SNP28 | TLR 7 (22,996) | 47 | 459 | * |
| SNP29 | TLR 8 (14) | 47 | 739 | * |
| SNP30 | TLR 8 (41) | 55 | 1029 | * |
| SNP31 | TLR 8 (124) | 52 | 628 | * |
| SNP32 | TLR 8 (176) | 55 | 577 | * |
| SNP33 | TLR 8 (265) | 56 | 807 | * |
| SNP34 | TLR 8 (534) | 56 | 402 | * |
| SNP35 | TLR 8 (570) | 59 | 377 | * |
| SNP36 | TLR 9 (872) | 55 | 681 | * |
| SNP37 | TLR 9 (905) | 55 | 653 | MSPA1I |
| SNP38 | TLR 9 (1126) | 57 | 506 | * |
| SNP39 | TLR 9 (1186) | 55 | 367 | * |
*: SNPs were confirmed by using ARMS-PCR without restriction of enzyme digestion.
Figure 1The detection of single nucleotide polymorphisms’ genotype distribution by ARMS-PCR. After the clean-up of PCR products, some were digested by RE, and PCR products were separated into different fragment sizes using 2% agarose gel electrophoresis to distinguish single-nucleotide variation. (A) Three genotypes, G/G, G/T, and T/T, in the SNP3 IFN-γ 490 gene. (B) Two genotypes, A/A and A/T, in the SNP19 TLR3 405 gene.
Figure 2Gating strategy for flow cytometry data. Representative dot plots illustrating the gated (A) lymphocytes population within leukocytes. The gating strategy for the evaluation of lymphocyte subpopulations—(B) CD4+, (C) CD8+, (D) CD80/86+, (E) MHCI+, (F) MHCII+. The frequency of cells is expressed as a percentage of positive cells in a lymphocyte gate.
The genotype distribution of SNPs in cytokine genes and their association with different pig breeds.
| Cytokine Polymorphism | Genotype Frequencies among Breed | |||||
|---|---|---|---|---|---|---|
| Genotype | Taiwan Black | Duroc | Landrace | Yorkshire | Landrace Yorkshire | |
| SNP1: IFN-α (−235) | ||||||
| A/A | 10 (37.04) | 0 | 2 (6.67) | 0 | 22 (28.57) | |
| A/G | 3 (11.11) | 20 (74.07) | 26 (86.67) | 25 (96.15) | 35 (45.45) | <0.0001 |
| G/G | 14 (51.85) | 7 (25.93) | 2 (6.67) | 1 (3.85) | 20 (25.97) | |
| Allele frequency | 0.57 | 0.63 | 0.5 | 0.51 | 0.49 | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | <0.0001 | 0.002 | <0.0001 | <0.0001 | 0.428 | |
| SNP2: IFN-γ (382) | ||||||
| C/C | 3 (11.1) | 12 (44.44) | 10 (33.33) | 1 (3.85) | 29 (37.66) | |
| C/T | 23 (85.2) | 15 (55.56) | 17 (56.67) | 12 (46.15) | 48 (62.34) | <0.0001 |
| T/T | 1 (3.7) | 0 | 3 (10) | 13 (50) | 0 | |
| Allele frequency | 0.46 | 0.28 | 0.38 | 0.73 | 0.28 | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | 0.0002 | 0.456 | 0.276 | 0.378 | 0.001 | |
| SNP3: IFN-γ (490) | ||||||
| G/G | 9 (37.5) | 0 | 12 (40) | 10 (38.46) | 6 (7.89) | |
| G/T | 9 (37.5) | 13 (48.15) | 15 (50) | 14 (53.85) | 47 (61.84) | <0.0001 |
| T/T | 6 (25) | 14 (51.85) | 3 (10) | 2 (7.69) | 23 (30.26) | |
| Allele frequency | 0.44 | 0.76 | 0.35 | 0.35 | 0.61 | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | 0.243 | 0.099 | 0.588 | 0.333 | 0.008 | |
| SNP4: TNF-α (366) | ||||||
| A/A | 12 (50) | 12 (48) | 0 | 0 | 17 (22.67) | |
| A/G | 9 (37.5) | 3 (12) | 2 (6.67) | 3 (11.54) | 7 (9.33) | <0.0001 |
| G/G | 3 (12.5) | 10 (40) | 28 (93.33) | 23 (88.46) | 51 (68) | |
| Allele frequency | 0.31 | 0.46 | 0.97 | 0.94 | 0.73 | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | 0.532 | <0.0001 | 0.85 | 0.754 | <0.0001 | |
| SNP5: TNF-α (755) | ||||||
| C/C | 3 (11.11) | 1 (3.7) | 12 (40) | 12 (46.15) | 13 (16.88) | |
| C/T | 10 (37.04) | 16 (59.26) | 16 (53.33) | 13 (50) | 62 (80.52) | <0.0001 |
| T/T | 14 (51.85) | 10 (37.04) | 2 (6.67) | 1 (3.85) | 2 (2.6) | |
| Allele frequency | 0.7 | 0.67 | 0.33 | 0.29 | 0.43 | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | 0.561 | 0.083 | 0.273 | 0.266 | <0.0001 | |
| SNP6: TNF-α (1219) | ||||||
| A/A | 10 (38.46) | 0 | 0 | 0 | 2 (2.6) | |
| A/G | 15 (57.69) | 26 (96.3) | 7 (23.33) | 6 (23.08) | 67 (87.01) | <0.0001 |
| G/G | 1 (3.85) | 1 (3.7) | 23 (76.67) | 20 (76.92) | 8 (10.39) | |
| Allele frequency | 0.33 | 0.52 | 0.88 | 0.88 | 0.54 | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | 0.112 | <0.0001 | 0.469 | 0.505 | <0.0001 | |
| SNP7: GM-CSF (193) | ||||||
| C/C | 0 | 0 | 11 (36.67) | 3 (12) | 4 (5.63) | |
| C/T | 1 (4.76) | 9 (33.33) | 14 (46.67) | 8 (32) | 35 (49.3) | <0.0001 |
| T/T | 20 (95.24) | 18 (66.67) | 5 (16.67) | 14 (56) | 32 (45.07) | |
| Allele frequency | 0.98 | 0.83 | 0.4 | 0.72 | 0.7 | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | 0.911 | 0.29 | 0.87 | 0.302 | 0.158 | |
| SNP8: GM-CSF (245) | ||||||
| C/C | 2 (10.53) | 4 (14.81) | 0 | 1 (3.85) | 1 (2.22) | |
| C/T | 10 (52.63) | 4 (14.81) | 22 (73.33) | 1(3.85) | 26 (57.78) | <0.0001 |
| T/T | 7 (36.84) | 19 (70.37) | 8 (26.67) | 24 (92.31) | 18 (40) | |
| Allele frequency | 0.63 | 0.78 | 0.63 | 0.94 | 0.69 | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | 0.568 | 0.002 | 0.001 | 0.0009 | 0.019 | |
| SNP10: GM-CSF (753) | n = 47 | |||||
| C/C | 3 (14.29) | 6 (22.22) | 7 (23.33) | 3 (11.54) | 27 (57.45) | |
| C/T | 9 (42.86) | 16(59.26) | 19 (63.33) | 23 (88.46) | 0 | <0.0001 |
| T/T | 9 (42.86) | 5(18.52) | 4 (13.33) | 0 | 20 (42.55) | |
| Allele frequency | 0.64 | 0.48 | 0.45 | 0.44 | 0.43 | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | 0.759 | 0.427 | 0.125 | <0.0001 | <0.0001 | |
| SNP11: GM-CSF (782) | ||||||
| C/C | 20 (86.96) | 17 (62.96) | 6 (20) | 14 (53.85) | 22 (29.33) | |
| C/T | 3 (13.04) | 10 (37.04) | 14 (46.67) | 10 (38.46) | 35 (46.67) | <0.0001 |
| T/T | 0 | 0 | 10 (33.33) | 2 (7.69) | 18 (24) | |
| Allele frequency | 0.07 | 0.19 | 0.57 | 0.27 | 0.47 | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | 0.737 | 0.237 | 0.785 | 0.908 | 0.579 | |
HWE, Hardy–Weinberg equilibrium; GM-CSF, granulocyte-macrophage colony-stimulating factor; a: χ2-test: different genotype distribution among the five different pig breeds, b: χ2-test: allele frequency among the three genotype groups, c: χ2-test: genotype distribution within each pig group, d: HWE test, p values less than 0.05 were not consistent with HWE.
Effects of SNPs in cytokine genes on the expressions of immunity parameters in pig lymphocytes.
| Cytokine Polymorphism | Immunity | Genotype | ||
|---|---|---|---|---|
| 1 | 2 | 3 | ||
| SNP1: IFN-α(-235) | A/A | A/G | G/G | |
| CD8 | 25.68 ± 3.22 a | 20.27 ± 1.18 a | 32.86 ± 2.42 b | |
| CD4:CD8 ratio | 1.39 ± 0.22 ab | 1.66 ± 0.14 a | 1.07 ± 0.09 b | |
| MHCII | 23.79 ± 2.45 a | 31.86 ± 1.32 b | 23.75 ± 1.95 a | |
| SNP2: IFN-γ (382) | C/C | C/T | T/T | |
| CD4 | 27.96 ± 2.61 a | 26.8 ± 1.22 a | 17.72 ± 2.30 b | |
| SNP3: IFN-γ (490) | G/G | G/T | T/T | |
| CD8 | 28.55 ± 2.79 a | 47.43 ± 4.5 b | 22.9 ± 1.95 a | |
| MHCII | 33.21 ± 2.48 a | 55.88 ± 4.18 b | 24.06 ± 1.76 c | |
| SNP4: TNF-α (366) | A/A | A/G | G/G | |
| CD8 | 26.13 ± 2.87 a | 28.57 ± 3.33 a | 22.24 ± 1.25 b | |
| MHCII | 29.06 ± 2.23 a | 23.07 ± 2.26 b | 29.83 ± 1.39 a | |
| SNP5: TNF-α (755) | C/C | C/T | T/T | |
| CD4 | 29.19 ± 3.01 a | 26.79 ± 1.29 ab | 20.31 ± 1.75 a | |
| CD8 | 26.8 ± 1.98 a | 20.99 ± 1.28 b | 34.05 ± 3.29 | |
| CD4:CD8 ratio | 1.2 ± 0.14 a | 1.73 ± 0.13 b | 0.74 ± 0.09 a | |
| MHCII | 36.68 ± 2.20 a | 25.55 ± 1.25 b | 32.29 ± 2.38 a | |
| SNP6: TNF-α (1219) | A/A | A/G | G/G | |
| CD8 | 41.04 ± 3.22 a | 21.34 ± 1.35 b | 25.85 ± 1.88 b | |
| CD4:CD8 ratio | 0.65 ± 0.12 | 1.6 ± 0.11 | 1.42 ± 0.21 | |
| MHCII | 31.83 ± 2.62 a | 25.14 ± 1.25 b | 35.64 ± 1.86 a | |
| SNP8: GM-CSF (245) | C/C | C/T | T/T | |
| CD4 | 21.31 ± 4.08 a | 30.75 ± 2.06 b | 23.36 ± 1.74 a | |
| CD8 | 19.58 ± 3.62 a | 29.41 ± 2.07 b | 22.35 ± 1.30 a | |
| MHCII | 14.23 ± 4.28 a | 30.14 ± 1.93 b | 31.19 ± 1.63 b | |
| SNP10: GM-CSF (753) | C/C | C/T | T/T | |
| CD4 | 31.78 ± 2.29 a | 24.13 ± 1.88 b | 23.81 ± 2.34 b | |
| MHCII | 21.07 ± 2.29 a | 35.9 ± 1.52 b | 29.15 ± 2.84 b | |
| SNP11: GM-CSF (782) | C/C | C/T | T/T | |
| CD8 | 25.86 ± 1.85 a | 24.29 ± 1.60 a | 18.26 ± 2.81 b | |
| CD4:CD8 ratio | 1.23 ± 0.10 a | 1.47 ± 0.16 a | 2.18 ± 0.33 b | |
Means with different letters in superscript (a, b, and c) are significantly different (p < 0.05).
The genotype distribution of SNPs in chemokine genes and their association with different pig breeds.
| Chemokine Polymorphism | Genotype Frequencies among Breed | |||||
|---|---|---|---|---|---|---|
| Genotype | Taiwan Black | Duroc | Landrace | Yorkshire | Landrace Yorkshire | |
| SNP15: MCP-1 (360) | ||||||
| C/C | 25 (92.59) | 6 (22.22) | 7 (23.33) | 3 (11.54) | 27 (35.06) | |
| C/T | 2 (7.41) | 1 (3.7) | 3 (10) | 0 | 0 | <0.0001 |
| T/T | 0 | 20 (74.07) | 20 (66.67) | 23 (88.46) | 50 (64.94) | |
| Allele frequency | 0.04 | 0.76 | 0.72 | 0.88 | 0.65 | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | 0.841 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| SNP16: MCP-1 (383) | n = 30 | |||||
| A/A | 23 (85.19) | 16 (59.26) | 27 (90) | 21 (80.77) | 77 (100) | |
| A/G | 2 (7.41) | 10 (37.04) | 0 | 5 (19.23) | 0 | <0.0001 |
| G/G | 2 (7.41) | 1 (3.7) | 3 (10) | 0 | 0 | |
| Allele frequency | 0.11 | 0.22 | 0.1 | 0.1 | - | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | 0.001 | 0.71 | <0.0001 | 0.587 | - | |
HWE, Hardy–Weinberg equilibrium; MCP-1, monocyte chemoattractant protein-1 a: χ2-test: different genotype distribution among the five different pig breeds, b: χ2-test: allele frequency among the three genotype groups, c: χ2-test: genotype distribution within each pig group, d: HWE test, p values less than 0.05 were not consistent with HWE.
Effects of SNPs in chemokine genes on the expression of immunity parameters in pig lymphocytes.
| Chemokine Polymorphism | Immune | Genotype | ||
|---|---|---|---|---|
| 1 | 2 | 3 | ||
| SNP13: MCP-1 (336) | A/A | A/C | C/C | |
| MHCII | 7.45 ± 0.55 a | 28.49 ± 1.01 b | 38.48 ± 6.75 c | |
| SNP15: MCP-1 (360) | C/C | C/T | T/T | |
| CD4 | 28.92 ± 1.70 ab | 32.86 ± 9.92 a | 23.98 ± 1.31 a | |
| CD8 | 31.26 ± 2.07 a | 32.46 ± 6.49 a | 18.92 ± 1.00 b | |
| CD4:CD8 ratio | 1.18 ± 0.09 a | 1.11 ± 0.23 a | 1.7 ± 0.15 b | |
| MHCII | 23.97 ± 1.59 a | 39.7 ± 11.81 b | 31.33 ±1.19 b | |
| SNP16:MCP-1 (383) | A/A | A/G | G/G | |
| CD8 | 24.66 ± 1.22 a | 16.94 ± 1.71 b | 32.46 ± 6.49 c | |
Means with different letters in superscript (a, b, and c) are significantly different (p < 0.05).
The genotype distribution of SNPs in TLR genes and their association with different pig breeds.
| TLR Polymorphism | Genotype Frequencies among Breed | |||||
|---|---|---|---|---|---|---|
| Genotype | Taiwan Black | Duroc | Landrace | Yorkshire | Landrace Yorkshire | |
| SNP17: TLR3 (95) | ||||||
| A/A | 10 (40) | 4 (15.38) | 10 (33.33) | 0 | 5 (6.49) | |
| A/G | 4 (16) | 1 (3.85) | 0 | 0 | 4 (5.19) | <0.0001 |
| G/G | 11 (44) | 21 (80.77) | 20 (66.67) | 26 (100) | 68 (88.31) | |
| Allele frequency | 0.52 | 0.83 | 0.67 | 1 | 0.91 | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | 0.0006 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| SNP20: TLR3 (800) | ||||||
| C/T | 8 (29.63) | 25 (96.15) | 29 (96.67) | 25 (96.15) | 69 (89.61) | <0.0001 |
| T/T | 19 (70.37) | 1 (3.85) | 1 (3.33) | 1 (3.85) | 8 (10.39) | |
| Allele frequency | 0.85 | 0.52 | 0.52 | 0.52 | 0.55 | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | 0.366 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| SNP23: TLR7 (66) | ||||||
| C/T | 3 (11.11) | 0 | 4 (13.33) | 1 (3.85) | 32 (41.56) | <0.0001 |
| T/T | 24 (88.89) | 26 (100) | 26 (86.67) | 12 (96.15) | 45 (58.44) | |
| Allele frequency | 0.94 | 1 | 0.93 | 0.96 | 0.79 | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | 0.759 | - | 0.695 | 0.885 | 0.021 | |
| SNP24: TLR7 (357) | ||||||
| A/G | 12 (46.15) | 22 (84.62) | 20 (68.97) | 13 (50) | 67 (87.01) | <0.0001 |
| G/G | 14 (53.85) | 4 (15.38) | 9 (31.03) | 13 (50) | 10 (12.99) | |
| Allele frequency | 0.77 | 0.58 | 0.66 | 0.75 | 0.56 | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | 0.126 | <0.0001 | 0.004 | 0.08 | <0.0001 | |
| SNP25: TLR7 (1413) | ||||||
| C/T | 2 (8.7) | 13 (50) | 25 (83.33) | 13 (46.15) | 35 (45.45) | <0.0001 |
| T/T | 21 (91.3) | 13 (50) | 5 (16.67) | 14 (53.85) | 42 (54.55) | |
| Allele frequency | 0.96 | 0.75 | 0.58 | 0.76 | 0.77 | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | 0.827 | 0.089 | <0.0001 | 0.099 | 0.009 | |
| SNP27: TLR7 (2034) | ||||||
| A/A | 11 (40.74) | 0 | 0 | 1 (3.85) | 0 | <0.0001 |
| A/G | 16 (59.26) | 26 (100) | 29 (100) | 25 (96.15) | 77 (100) | |
| Allele frequency | 0.3 | 0.5 | 0.5 | 0.48 | 0.5 | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | 0.028 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| SNP30: TLR8 (41) | ||||||
| G/G | 0 | 0 | 1 (3.33) | 0 | 3 (3.9) | |
| G/T | 7 (25.93) | 0 | 11 (36.67) | 24 (92.31) | 29 (37.66) | <0.0001 |
| T/T | 20 (74.07) | 26 (100) | 18 (60) | 2 (7.69) | 45 (58.44) | |
| Allele frequency | 0.87 | 1 | 0.78 | 0.54 | 0.77 | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | 0.438 | - | 0.66 | <0.0001 | 0.525 | |
| SNP34: TLR8 (534) | ||||||
| A/A | 1 (3.7) | 0 | 0 | 0 | 1 (1.3) | |
| A/C | 26 (96.3) | 26 (100) | 30 (100) | 26 (100) | 52 (67.53) | <0.0001 |
| C/C | 0 | 0 | 0 | 0 | 24 (31.17) | |
| Allele frequency | 0.48 | 0.5 | 0.5 | 0.5 | 0.65 | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| SNP35: TLR8 (570) | ||||||
| A/A | 14 (51.85) | 0 | 0 | 0 | 1 (1.3) | <0.0001 |
| A/T | 13 (48.15) | 26 (100) | 30 (100) | 26 (100) | 76 (98.7) | |
| Allele frequency | 0.24 | 0.5 | 0.5 | 0.5 | 0.49 | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | 0.099 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| SNP39: TLR9 (1186) | ||||||
| C/C | 7 (25.93) | 0 | 0 | 0 | 0 | <0.0001 |
| C/T | 20 (74.07) | 27 (100) | 30 (100) | 26 (100) | 27 (100) | |
| Allele frequency | 0.37 | 0.5 | 0.5 | 0.5 | 0.5 | |
| Genotype distribution | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| HWE | 0.002 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
HWE, Hardy–Weinberg equilibrium; TLR, Toll-like receptor a: χ2-test: different genotype distribution among the five different pig breeds, b: χ2-test: allele frequency among the three genotype groups, c: χ2-test: genotype distribution within each pig group, d: HWE test, p values less than 0.05 were not consistent with HWE.
Effects of SNPs in Toll-like receptor genes on the expressions of immunity parameters in pig lymphocytes.
| TLR Polymorphism | Immune | Genotype | ||
|---|---|---|---|---|
| 1 | 2 | 3 | ||
| SNP17: TLR 3 (95) | A/A | A/G | G/G | |
| CD8 | 28.25 ± 2.66 ab | 33.29 ± 6.00 a | 22.44 ± 1.22 b | |
| CD4:CD8 ratio | 1.02 ± 0.12 a | 0.9 ± 0.16 a | 1.63 ± 0.12 b | |
| SNP18: TLR 3 (159) | C/C | C/T | T/T | |
| CD4:CD8 ratio | 1.64 ± 0.21 a | 1.82 ± 0.23 a | 1.28 ± 0.07 b | |
| SNP21: TLR 4 (-13) | A/A | A/G | G/G | |
| CD8 | 15.85 ± 1.54 a | 22.46 ± 1.36 a | 15.64 ± 1.32 a | |
| MHCII | 23.31 ± 1.82 a | 37.23 ± 1.49 b | 17.59 ± 1.45 c | |
| SNP34: TLR 8 (534) | A/A | A/C | C/C | |
| CD4 | 36.25 ± 11.05 a | 24.34 ± 1.00 b | 39.27 ± 4.18 a | |
| CD8 | 32.85 ± 11.05 a | 22.53 ± 1.11 b | 35.65 ± 3.77 a | |
Means with different letters in superscript (a, b, and c) are significantly different (p < 0.05).